Showing results (241-250 of 2,319) with videos related to

Sort By:
Pageof 232
Expert Opinion on Therapeutic Targets|December 16, 2014
The η-class carbonic anhydrases as drug targets for antimalarial agentsClaudiu T Supuran, Clemente Capasso
Expert Opinion on Therapeutic Targets|December 16, 2014
The potential of targeting NMDA receptors outside the CNSMilica Bozic, José M Valdivielso
Expert Opinion on Therapeutic Targets|September 13, 2014
Atypical PKC: a target for treating insulin-resistant disorders of obesity, the metabolic syndrome and type 2 diabetes mellitusRobert V Farese, Mackenzie C Lee, Mini P Sajan
Expert Opinion on Therapeutic Targets|November 15, 2014
Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatmentAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Expert Opinion on Therapeutic Targets|July 28, 2015
Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?Antonio Gnoni, Daniele Santini, Mario Scartozzi, et al.
Expert Opinion on Therapeutic Targets|August 18, 2017
Implications of Bcl-2 and its interplay with other molecules and signaling pathways in prostate cancer progressionJu-Ha Kim, Hyemin Lee, Eun Ah Shin, et al.
Expert Opinion on Therapeutic Targets|October 25, 2017
The eIF2-alpha kinase HRI: a potential target beyond the red blood cellNicholas Burwick, Bertal H Aktas
Expert Opinion on Therapeutic Targets|October 1, 2015
Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesisNicole Rainville, Edward Jachimowicz, Don M Wojchowski
Pageof 232